AstraZeneca buys Bristol-Myers Squibb's stake in diabetes alliance for $4.1B By: Business Journals December 19, 2013 at 08:54 AM EST AstraZeneca reached an agreement Thursday to acquire Bristol-Myers Squibb's global diabetes business for up to $4... Read More >> Related Stocks: Bristol-Myers Squibb